A retrospective series of 11 patients with liver failure found low-dose regional citrate combined with nafamostat feasible ...
The US FDA has approved Hibisago, a new injectable treatment for chronic hepatitis B. Clinical trials show promise, but ...
Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...
Dr. Norah Terrault, Chief of Gastroenterology & Hepatology, USC Keck Medical Center, said: “This is the start of a new era in treating people living with CHB. Bepirovirsen offers patients the ...
Anti-CD36 alloimmunization may contribute to severe platelet transfusion refractoriness despite negative human leukocyte ...
Parkinson’s patients elevated baseline inflammation demonstrated statistically significant improvements in both motor and non ...
A Guadeloupe study found increased platelet activation and caspase-1 activity in adults with sickle cell disease at steady state, with hemolysis-linked associations concentrated among patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results